ROGERSVILLE — Less than three weeks from the beginning of his sexual battery trial, Rogersville pediatrician Dr. Chris Calendine is now facing 39 new charges related to allegations of prescription fraud.

In August 2017, Dr. Christopher Lawrence “Chris” Calendine was indicted on one count of aggravated sexual battery and one count of sexual battery by an authority figure for allegedly touching two boys ages 12 and 14 during a sleepover at his Rogersville home. He faces a maximum sentence of eight years on one count and up to six years on the other.

Calendine adamantly denies all allegations, and he has maintained business as usual at his medical practice since being indicted. His trial is scheduled to begin Sept. 24 in Hawkins County Criminal Court.

Calendine, 46, 261 Rivergate Manor, Rogersville, was arrested on that sealed indictment warrant Wednesday evening and released on $20,000 bond.

The charges are the result of an investigation by the Attorney General’s office into Calendine’s past in which three witnesses were uncovered who made allegations of sexual assault against Calendine dating back to the 1990s.

Attorney General Dan Armstrong was seeking to have those witnesses permitted to testify before the jury at Calendine's trial.

During the course of gathering information from those witnesses, it was revealed that in 2013 Calendine allegedly sent an email to one of those witnesses in which he admitted to prescribing Aderrall, a Schedule II narcotic, to another male, but using the drug himself.

When investigators began looking into the Adderall claim, they compiled enough evidence to acquire indictments on 39 counts of identity theft.

Adderall isn’t mentioned in the indictment, however. Instead, Calendine is accused of acquiring Cytomel tablets using another person’s identity without that person’s knowledge on 39 occasions between Dec. 15, 2004, and July 29, 2018.

Cytomel is a synthetic form of thyroid hormone used to to treat thyroid cancer patients, but it is also used to increase metabolism, and in treating major depressive disorder when used in combination with antidepressants.